Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Jun 11:56:jrm25491.
doi: 10.2340/jrm.v56.25491.

Diaphragmatic strengthening exercises for patients with post COVID-19 condition after mild-to-moderate acute COVID-19 infection: a randomized controlled study

Tamer I Abo Elyazed  1 , Ahmed Abd El-Moneim Abd El-Hakim  2 , Ola I Saleh  3 , Marwa Mostafa Fadel Sonbol  3 , Hoda Assad Eid  4 , Eman Moazen  5 , Mohammad Hamad Alhassoon  6 , Seham Ezzat Fathy Elfeky  7
Affiliations
Randomized Controlled Trial

Diaphragmatic strengthening exercises for patients with post COVID-19 condition after mild-to-moderate acute COVID-19 infection: a randomized controlled study

Tamer I Abo Elyazed et al. J Rehabil Med. .

Abstract

Objective: To assess the clinical effects of incentive spirometry (IS) and diaphragmatic breathing (DB) in patients with post COVID-19 condition and diaphragmatic dysfunction as compared with the standard care alone.

Methods: The present longitudinal randomized study included 60 patients with post COVID-19 condition and diaphragmatic dysfunction. Patients were equally randomized to receive standard care plus IS (G1), standard care plus DB (G2) or standard care alone (G3) for 8 weeks. The primary outcome is clinical improvement as evaluated by the modified Medical Research Council (mMRC) dyspnoea scale.

Results: Comparison between the studied groups revealed significant improvement in G1 and G2 in all parameters at the end of follow-up. However, no significant improvement was found in G3. At the end of follow-up, 15 patients (75.0%) in G1, 11 patients (55.0%) in G2, and 3 patients (15.0%) in G3 showed improvement on the mMRC dyspnoea scale. Multivariate logistic regression analysis identified mild acute COVID-19 infection (p = 0.009), use of IS (p < 0.001), and use of DB (p = 0.023) as significant predictors of improvement on the mMRC dyspnoea scale.

Conclusions: IS or DB training in addition to the standard care in post COVID-19 condition was associated with better clinical improvement as compared with the standard care alone.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Meng QT, Song WQ, Churilov LP, Zhang FM, Wang YF. Psychophysical therapy and underlying neuroendocrine mechanisms for the rehabilitation of long COVID-19. Front Endocrinol (Lausanne) 2023; 14: 1120475. DOI: 10.3389/fendo.2023.1120475 - DOI - PMC - PubMed
    1. Hawley HB. Long COVID: clinical findings, pathology, and endothelial molecular mechanisms. Am J Med 2023: S0002-9343(23)00539-9. DOI: 10.1016/j.amjmed.2023.08.008 - DOI - PubMed
    1. Li H, Xia J, Bennett D, Roque F, Bam RA, Tavares ABT, et al. . Long-COVID-19 clinical and health outcomes: an umbrella review. Ther Adv Infect Dis 2023; 10: 20499361231198335. DOI: 10.1177/20499361231198335 - DOI - PMC - PubMed
    1. Sapna F, Deepa F, Sakshi F, Sonam F, Kiran F, Perkash RS, et al. . Unveiling the mysteries of long COVID syndrome: exploring the distinct tissue and organ pathologies linked to prolonged COVID-19 symptoms. Cureus 2023; 15: e44588. DOI: 10.7759/cureus.44588 - DOI - PMC - PubMed
    1. Tsilingiris D, Vallianou NG, Karampela I, Christodoulatos GS, Papavasileiou G, Petropoulou D, et al. . Laboratory findings and biomarkers in long COVID: what do we know so far? Insights into epidemiology, pathogenesis, therapeutic perspectives and challenges. Int J Mol Sci 2023; 24: 10458. DOI: 10.3390/ijms241310458 - DOI - PMC - PubMed

Publication types